While traditional induction therapy for newly diagnosed stage 2 myeloma often focuses on combinations of proteasome inhibitors, immunomodulatory drugs, and steroids, these newer immunotherapy classes ...

Strong patient demand and expanding trial sites are helping Paradigm progress its long-awaited phase III knee OA study.

Doctors suggest a mix of aerobic exercise, such as running or walking, and strength training, which slows the loss of bone ...

But in findings presented at the American College of Allergy, Asthma and Immunology (ACAAI) meeting in Orlando, the novel ...

The Food and Drug Administration is adding a new warning to a gene therapy linked to two patient deaths earlier this year ...

Near-term applications include combinations with kinase inhibitors (KIs)that achieve enhanced concentration at target sites and synergistic delivery of multiple KIs to the same location ...

The U.S. Food and Drug Administration (FDA) approved Poherdy (pertuzumab-dpzb) as the first interchangeable biosimilar to ...

There is still no cure, and most treatments only help with symptoms instead of stopping the disease itself. But a team of ...

San Francisco Mayor Daniel Lurie is unveiling a new plan to tackle the city's drug crisis, which involves opening up a new ...

WhiteSands Alcohol & Drug Rehab Orlando has published a new resource titled Accepted Insurances, available on ...

The FDA has cleared a phase 3 trial for lacutamab in CTCL, following promising phase 2 results showing durable activity and safety. TELLOMAK 3 will assess progression-free survival with two cohorts: ...

Mayor Daniel Lurie is hoping a new, coercive approach can help officers tackle open-air drug use in San Francisco while getting more people off the streets and connected to addiction treatment.